Učitavanje...

Omalizumab decreases IgE production in patients with allergic (IgE-mediated) asthma; PKPD analysis of a biomarker, total IgE

AIM: To determine whether excessive IgE production by patients with atopic allergic asthma decreases with omalizumab therapy. METHODS: Omalizumab, free and total IgE data were obtained from an epidemiological study and six randomized, double-blind, placebo-controlled trials in patients with allergic...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Lowe, Philip J, Renard, Didier
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Science Inc 2011
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3162660/
https://ncbi.nlm.nih.gov/pubmed/21392073
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2011.03962.x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!